These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 35669305)
21. Inpatient Transition to Virtual Care During COVID-19 Pandemic. Jones MS; Goley AL; Alexander BE; Keller SB; Caldwell MM; Buse JB Diabetes Technol Ther; 2020 Jun; 22(6):444-448. PubMed ID: 32396395 [No Abstract] [Full Text] [Related]
22. The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth. Peters AL; Garg SK Diabetes Technol Ther; 2020 Jun; 22(6):449-453. PubMed ID: 32383989 [No Abstract] [Full Text] [Related]
23. Covid-19 and Health Care's Digital Revolution. Keesara S; Jonas A; Schulman K N Engl J Med; 2020 Jun; 382(23):e82. PubMed ID: 32240581 [No Abstract] [Full Text] [Related]
24. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). Fokkert M; van Dijk P; Edens M; Barents E; Mollema J; Slingerland R; Gans R; Bilo H BMJ Open Diabetes Res Care; 2019; 7(1):e000809. PubMed ID: 31875133 [TBL] [Abstract][Full Text] [Related]
25. Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study. Charleer S; De Block C; Van Huffel L; Broos B; Fieuws S; Nobels F; Mathieu C; Gillard P Diabetes Care; 2020 Feb; 43(2):389-397. PubMed ID: 31843948 [TBL] [Abstract][Full Text] [Related]
26. A Virtual Type 2 Diabetes Clinic Using Continuous Glucose Monitoring and Endocrinology Visits. Dixon RF; Zisser H; Layne JE; Barleen NA; Miller DP; Moloney DP; Majithia AR; Gabbay RA; Riff J J Diabetes Sci Technol; 2020 Sep; 14(5):908-911. PubMed ID: 31762302 [TBL] [Abstract][Full Text] [Related]
28. A View Beyond HbA1c: Role of Continuous Glucose Monitoring. Chehregosha H; Khamseh ME; Malek M; Hosseinpanah F; Ismail-Beigi F Diabetes Ther; 2019 Jun; 10(3):853-863. PubMed ID: 31037553 [TBL] [Abstract][Full Text] [Related]
29. Continuous glucose monitoring: an emerging standard of care. Welsh JB; Thomas R Am J Manag Care; 2019 Mar; 25(4 Spec No.):SP116-SP119. PubMed ID: 30933460 [No Abstract] [Full Text] [Related]
30. Mobile health in the management of type 1 diabetes: a systematic review and meta-analysis. Wang X; Shu W; Du J; Du M; Wang P; Xue M; Zheng H; Jiang Y; Yin S; Liang D; Wang R; Hou L BMC Endocr Disord; 2019 Feb; 19(1):21. PubMed ID: 30760280 [TBL] [Abstract][Full Text] [Related]
31. The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c. Beck RW; Bergenstal RM; Cheng P; Kollman C; Carlson AL; Johnson ML; Rodbard D J Diabetes Sci Technol; 2019 Jul; 13(4):614-626. PubMed ID: 30636519 [TBL] [Abstract][Full Text] [Related]
32. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Bergenstal RM; Beck RW; Close KL; Grunberger G; Sacks DB; Kowalski A; Brown AS; Heinemann L; Aleppo G; Ryan DB; Riddlesworth TD; Cefalu WT Diabetes Care; 2018 Nov; 41(11):2275-2280. PubMed ID: 30224348 [TBL] [Abstract][Full Text] [Related]
33. Clinical Effectiveness of Telemedicine in Diabetes Mellitus: A Meta-Analysis of 42 Randomized Controlled Trials. Tchero H; Kangambega P; Briatte C; Brunet-Houdard S; Retali GR; Rusch E Telemed J E Health; 2019 Jul; 25(7):569-583. PubMed ID: 30124394 [No Abstract] [Full Text] [Related]
34. Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control. Riddlesworth TD; Beck RW; Gal RL; Connor CG; Bergenstal RM; Lee S; Willi SM Diabetes Technol Ther; 2018 Apr; 20(4):314-316. PubMed ID: 29565197 [TBL] [Abstract][Full Text] [Related]
35. The Fallacy of Average: How Using HbA Beck RW; Connor CG; Mullen DM; Wesley DM; Bergenstal RM Diabetes Care; 2017 Aug; 40(8):994-999. PubMed ID: 28733374 [TBL] [Abstract][Full Text] [Related]
36. Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes. Haak T; Hanaire H; Ajjan R; Hermanns N; Riveline JP; Rayman G Diabetes Ther; 2017 Jun; 8(3):573-586. PubMed ID: 28401454 [TBL] [Abstract][Full Text] [Related]
37. Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials. Faruque LI; Wiebe N; Ehteshami-Afshar A; Liu Y; Dianati-Maleki N; Hemmelgarn BR; Manns BJ; Tonelli M; CMAJ; 2017 Mar; 189(9):E341-E364. PubMed ID: 27799615 [TBL] [Abstract][Full Text] [Related]
38. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Bolinder J; Antuna R; Geelhoed-Duijvestijn P; Kröger J; Weitgasser R Lancet; 2016 Nov; 388(10057):2254-2263. PubMed ID: 27634581 [TBL] [Abstract][Full Text] [Related]
39. Associations between adherence and outcomes among older, type 2 diabetes patients: evidence from a Medicare Supplemental database. Boye KS; Curtis SE; Lage MJ; Garcia-Perez LE Patient Prefer Adherence; 2016; 10():1573-81. PubMed ID: 27574406 [TBL] [Abstract][Full Text] [Related]
40. Differences in the management of type 1 diabetes among adults under excellent control compared with those under poor control in the T1D Exchange Clinic Registry. Simmons JH; Chen V; Miller KM; McGill JB; Bergenstal RM; Goland RS; Harlan DM; Largay JF; Massaro EM; Beck RW; Diabetes Care; 2013 Nov; 36(11):3573-7. PubMed ID: 24026543 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]